Results 271 to 280 of about 168,682 (384)

Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy

, 2002
Otto Kollmar, Sandra Becker, Martin Schilling, Christoph A. Maurer   +3 more
openalex   +1 more source

Store-operated Cation Entry Mediated by CD20 in Membrane Rafts [PDF]

, 2003
Haidong Li, Linda M. Ayer, Jonathan Lytton, Julie P. Deans   +3 more
openalex   +1 more source

T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells

Cancer immunology research, 2016
Eugenia Zah, Meng-Yin Lin, Anne Silva-Benedict, M. Jensen, Y. Chen   +4 more
semanticscholar   +1 more source

A Confusing Case of Confusion: Bing-Neel Syndrome Treated With Zanubrutinib. [PDF]

EJHaem
Duell H, Clarke A, Bugg S.
europepmc   +1 more source

Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20‐year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)

British Journal of Haematology, EarlyView.
We report the UK experience of autologous haematopoietic stem cell transplantation (AHSCT) for multiple sclerosis (MS) in 364 patients. In our observational study, transplant‐related mortality was 1.4%, Epstein–Barr virus reactivation occurred in 75.9%, while disability progression‐free survival was 83.5% at 2 years post‐AHSCT and 62.4% at 5 years.
Majid Kazmi, Paolo A. Muraro, Varun Mehra, Ian Gabriel, Eleonora De Matteis, Gavin Brittain, Alice Mariottini, Richard Nicholas, Eli Silber, Julia Lee, Rachel Pearce, Ruth Paul, Maria Pia Sormani, Alessio Signori, Victoria Potter, Eduardo Olavarria, Ram Malladi, Basil Sharrack, John A. Snowden   +18 more
wiley   +1 more source

Extracellular Vesicles Profile and Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma. [PDF]

Int J Mol Sci
Otasevic V, Gran C, Milic N, Ivanovic J, Kozarac S, Vukovic V, Mihaljevic B, Dukic N, Masic JV, Fareed J, Antovic J, Antic D.   +11 more
europepmc   +1 more source

The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas

British Journal of Haematology, EarlyView.
Follicular lymphoma (FL), marginal zone lymphoma (MZL), chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL) are characterized by a continuous incidence of relapse and increasing resistance to therapy. Novel immunotherapy approaches are needed.
Rahul Lakhotia, Christopher Melani, Stefania Pittaluga, Max J. Gordon, James D. Phelan, Jagan R. Muppidi, Atekelt Tadese, Sarah Evans, Elaine S. Jaffe, Louis M. Staudt, Wyndham H. Wilson, Mark Roschewski   +11 more
wiley   +1 more source

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study. [PDF]

Sci Rep
Li X, Liu Y, Zhu X, Jin H, Zhang X, Wang L, Cui Y, Xu F, Wang Y, Song Y, Cui W.   +10 more
europepmc   +1 more source

Lymphomatoid Papulosis Following Spesolimab Treatment for Generalised Pustular Psoriasis

Australasian Journal of Dermatology, EarlyView.
Mizuho Namba, Mika Matsumoto, Naoya Saito, Atsuko Kimura, Chihiro Sagara, Daiki Rokunohe, Eijiro Akasaka   +6 more
wiley   +1 more source

Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and cd20‐negative multiple myeloma [PDF]

, 2003
Silvia Höfer, Sabina Hunziker, Stephan Dirnhofer, Christian Ludwig   +3 more
openalex   +1 more source